DREAM-01 |
Microbicides, Multipurpose Prevention Technologies |
I |
October 2016 |
United States of America, Malawi |
Men |
|
Ongoing |
MTN 042 |
Microbicides |
III |
|
Malawi, South Africa, Uganda, Zimbabwe |
Pregnant women, Women |
Dapivirine Ring, TDF/FTC (Truvada) |
Ongoing |
MTN 003D |
Microbicides, PrEP |
Other |
December 2012 |
South Africa, Uganda, Zimbabwe |
Women |
|
Completed |
MTN-003C (VOICE Community Substudy) |
Microbicides, PrEP |
Other |
June 2010 |
South Africa |
Women |
|
Completed |
MTN 003B |
Microbicides |
IIb |
November 2009 |
Zimbabwe, Uganda |
Women |
TDF/FTC (Truvada) |
Completed |
TRIO Study (Tablets, Rings, and Injectables as Options for women) |
Microbicides, Multipurpose Prevention Technologies |
Other |
November 2014 |
Kenya, South Africa |
Women |
|
Completed |
EMOTION - Enhancing Microbicide Uptake in High-Risk End Users |
Microbicides, PrEP |
Other |
July 2016 |
Kenya, South Africa, Zimbabwe |
Women |
|
Ongoing |
MTN 038 |
Microbicides |
I |
December 2018 |
United States of America |
Women |
TFV ring |
Ongoing |
MTN-039 |
Microbicides, Multipurpose Prevention Technologies |
Open Label, I |
December 2019 |
United States of America |
Men, Women |
Elvitegravir (EVG) |
Ongoing |
Safety and Pharmacokinetic Study of HIV Prophylaxis Using Antiretroviral Intravaginal Rings in Healthy Women |
Microbicides |
Open Label |
June 2015 |
United States of America |
|
TDF, TDF/FTC (Truvada), Maraviroc |
Completed |
Safety and Pharmacokinetics (PK) of a Polyurethane Tenofovir Disoproxil Fumarate (TDF) Vaginal Ring (TDF IVR-002) |
Microbicides |
I |
January 2017 |
United States of America, Kenya |
Women |
TDF |
Stopped Early |
The Quatro Study |
Microbicides |
Open Label |
November 2015 |
South Africa, Zimbabwe |
Women |
|
Completed |
Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel in HIV-1 Seronegative Adults (CHARM-03) |
Microbicides |
I |
January 2015 |
United States of America |
Women, Men |
Maraviroc |
Completed |
CONRAD 128 |
Microbicides, Multipurpose Prevention Technologies |
I |
October 2014 |
Dominican Republic, United States of America |
Women |
tenofovir, Levonorgestrel |
Completed |
Film Antiretroviral Microbicide Evaluation (FAME-02) |
Microbicides |
I |
August 2012 |
United States of America |
Women |
dapivirine gel |
Completed |
Comparison of Tenofovir Vaginal Gel and Film Formulations (FAME-05) |
Microbicides |
Open Label |
November 2014 |
|
Women |
1% tenofovir gel, tenofovir |
Completed |
A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04 |
Microbicides, Multipurpose Prevention Technologies |
I |
November 2013 |
United States of America |
Women |
1% tenofovir gel, HEC gel, tenofovir |
Completed |
Pre-exposure prevention of viral entry (PREVENT) |
Microbicides |
Pre-clinical |
January 2014 |
United States of America |
|
GRFT |
|
IPM 020 |
Microbicides |
II, I |
June 2009 |
United States of America |
Women |
dapivirine gel |
Completed |
IPM 014B |
Microbicides |
II, I |
July 2009 |
South Africa |
Women |
dapivirine gel |
Completed |